Skip to main content

Lishomwa C Ndhlovu

NIH Rank #339
  • Program Leader
  • Top 5% Funded
  • R01 Holder
  • Multi-Institutional
  • Early Career
  • Diverse Portfolio

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 9476960Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Pathology
  • VETERINARY SCIENCES
  • Microbiology & Immunology

NIH Funding · FY2026

Linked Award Amount
$7M
Full award amounts, FY2026
Award Records
6
Records listing this PI
Award-Linked Rank
#339
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Lishomwa C Ndhlovu. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2026 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2026 award records by amount

NIH award records listing Lishomwa C Ndhlovu as a PI. Multi-PI records show the full award amount for context.

  • 5U01DA058527-04U01
    Elucidating single cell changes in neurogenic brain regions during HIV and cannabinoid exposure
    $2.3M
    award amount
  • 5R37AI189285-02R37
    Characterization of Allogeneic T Cells Mediating HIV Cure
    $1.6M
    award amount
  • 5R01MH130177-05R01
    Targeting CNS reservoirs with CAR/CXCR5 T cells for the long-term remission of HIV
    $893.5K
    award amount
  • 5R01AI184421-03R01
    Modulation of Galectin-9 to Target HIV Persistence
    $827.5K
    award amount
  • 5R01AI179324-04R01
    Defining the Immunogenicity and Efficacy of a Durable BCG Vaccine Strategy Optimized for Preventing TB in Pediatric HIV Infection
    $776.7K
    award amount
  • 5R01DA063076-02R01
    Single cell dark matter in the context of HIV and substance use
    $589.2K
    award amount

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #231
  8. 2024
    Entered Top 25% Nationally
    Ranked #231
  9. 2024
    Entered Top 10% Nationally
    Ranked #231
  10. 2024
    Entered Top 5% Nationally
    Ranked #231
  11. 2025
    $25M Cumulative Funding
  12. 2025
    Multi-Institutional Research
    Awards at 6 institutions
  13. 2025
    R01 Grant Holder
  14. 2025
    Program/Center Grant Leader